The Hospital Clínic launches an immunotherapy home infusion programme
The Hospital Clínic Medical Oncology Service, led by Dr. Aleix Prat, has launched a home infusion programme for solid organ cancer patients and imm...
Service News from Medical Oncology
Seven specialities at the Hospital Clínic among the best in the world, according to Newsweek’s World's Best Specialized Hospitals 2022
Cardiology, cardiac surgery, orthopaedic surgery and traumatology, gastroenterology, endocrinology and nutrition, neurology and medical oncology ar...
Launch of a pioneering clinical trial to validate the efficacy of immunotherapy in 29 types of tumour
The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 2...
A molecular classification predicts the prognosis and the benefit of a cell cycle inhibitor in metastatic breast cancer
In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity...
The UB creates the Chair on Innovation in Precision Oncology
Dr. Aleix Prat, head of the Service of Medical Oncology at Hospital Clínic, head of the Translational genomics and targeted therapies in solid tumo...
The UB, Hospital Clínic and AstraZeneca create a knowledge transfer chair on lung cancer
The University of Barcelona, Hospital Clínic and the pharmaceutical company AstraZeneca created the UB-Hospital Clínic Chair on Lung Cancer AstraZe...
EuCanImage: Next-generation artificial intelligence in oncology
Reserachers of Hospital Clínic-IDIBAPS participate in EuCanImage, a project from the Horizon 2020 program that will build a federated and scalable...
Spin-off Reveal Genomics born to develop innovative diagnostic tests in oncology
Reveal Genomics’ first goal will be to develop diagnostic tools based on complex genomic data for patients with advanced breast cancer.
Immunotherapy: an innovative and efficient tool in the battle against haematological tumours
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘imm...
A new biological treatment could replace chemotherapy in patients with aggressive breast cancer
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publ...